BIIB in the 13F filings
Biogen Inc · CUSIP 09062X103
- Quarter end
- 30 Jun 2025
- the date the book describes
- Filed
- 18 Aug 2025
- latest of these filings; the earliest 7 Aug 2025
- Managers listing it
- 20
- at least, of 95 tracked, among listed positions
- Comparable managers
- 95
- filed both Q1 2025 and Q2 2025; 14 listed it in both
- Shares listed
- 20,231,031
- combined, among listed positions
- Reported value
- $2.5bn
- combined, at the quarter end
Among the 95 comparable managers: 15 buyers (opened or added shares) and 5 sellers (trimmed or exited), at least, among listed positions. Their net change in shares is not known from listed positions, because at least one of them lists it in only one of the two quarters.
Managers listing BIIB in Q2 2025
20 of 20 holders
Largest increases and reductions, by shares
Increases
- Point72 Asset Management LPexisting position · 3,831,727 shares now+3,424,470
- Arrowstreet Capital LPexisting position · 624,371 shares now+409,591
- Renaissance Technologies LLCexisting position · 1,045,106 shares now+240,600
- Wellington Management Group LLPexisting position · 4,798,420 shares now+125,983
- Freestone Grove Partners LPnew position · 111,004 shares now+111,004
Reductions
- Two Sigma Investments LPexisting position · 507,539 shares now-371,791
- Two Sigma Advisers LPexisting position · 455,500 shares now-221,900
- D. E. Shaw & Co.existing position · 1,366,207 shares now-219,365
- Woodline Partners LPexisting position · 95,560 shares now-29,602
- AQR Capital Management LLCexisting position · 1,364,805 shares now-4,037
New positions and exits
New (3)
Exited (0)
No exit shown by a manager’s own filing.
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q2 2013 | 23 | $12.7bn | n.a. | n.a. |
| Q3 2013 | 20 | $14.3bn | n.a. | n.a. |
| Q4 2013 | 20 | $16.1bn | n.a. | n.a. |
| Q1 2014 | 21 | $16.8bn | n.a. | n.a. |
| Q2 2014 | 18 | $16.8bn | n.a. | n.a. |
| Q3 2014 | 23 | $16.4bn | n.a. | n.a. |
| Q4 2014 | 22 | $15.7bn | n.a. | n.a. |
| Q1 2015 | 24 | $20.3bn | n.a. | n.a. |
| Q2 2015 | 24 | $20.5bn | n.a. | n.a. |
| Q3 2015 | 24 | $12.4bn | n.a. | n.a. |
| Q4 2015 | 27 | $11.9bn | n.a. | n.a. |
| Q1 2016 | 27 | $10.3bn | n.a. | n.a. |
| Q2 2016 | 24 | $9.5bn | n.a. | n.a. |
| Q3 2016 | 29 | $11.6bn | n.a. | n.a. |
| Q4 2016 | 31 | $10.9bn | n.a. | n.a. |
| Q1 2017 | 25 | $9.2bn | n.a. | n.a. |
| Q2 2017 | 28 | $9.8bn | n.a. | n.a. |
| Q3 2017 | 24 | $11.6bn | n.a. | n.a. |
| Q4 2017 | 22 | $11.8bn | n.a. | n.a. |
| Q1 2018 | 28 | $9.6bn | n.a. | n.a. |
| Q2 2018 | 25 | $8.9bn | n.a. | n.a. |
| Q3 2018 | 28 | $10.6bn | n.a. | n.a. |
| Q4 2018 | 28 | $9.0bn | n.a. | n.a. |
| Q1 2019 | 22 | $7.4bn | n.a. | n.a. |
| Q2 2019 | 28 | $7.2bn | n.a. | n.a. |
| Q3 2019 | 28 | $7.1bn | n.a. | n.a. |
| Q4 2019 | 27 | $7.7bn | n.a. | n.a. |
| Q1 2020 | 25 | $7.3bn | n.a. | n.a. |
| Q2 2020 | 29 | $5.1bn | n.a. | n.a. |
| Q3 2020 | 25 | $5.1bn | n.a. | n.a. |
| Q4 2020 | 22 | $4.6bn | n.a. | n.a. |
| Q1 2021 | 18 | $4.7bn | n.a. | n.a. |
| Q2 2021 | 25 | $5.4bn | n.a. | n.a. |
| Q3 2021 | 23 | $3.3bn | n.a. | n.a. |
| Q4 2021 | 25 | $3.7bn | n.a. | n.a. |
| Q1 2022 | 29 | $3.7bn | n.a. | n.a. |
| Q2 2022 | 25 | $3.4bn | n.a. | n.a. |
| Q3 2022 | 33 | $5.2bn | n.a. | n.a. |
| Q4 2022 | 28 | $5.0bn | n.a. | n.a. |
| Q1 2023 | 30 | $5.1bn | n.a. | n.a. |
| Q2 2023 | 23 | $4.4bn | n.a. | n.a. |
| Q3 2023 | 21 | $2.9bn | n.a. | n.a. |
| Q4 2023 | 17 | $2.8bn | 11 | 8 |
| Q1 2024 | 16 | $2.5bn | 9 | 10 |
| Q2 2024 | 14 | $2.5bn | 6 | 8 |
| Q3 2024 | 17 | $2.6bn | 15 | 2 |
| Q4 2024 | 20 | $2.6bn | 16 | 4 |
| Q1 2025 | 22 | $2.4bn | 15 | 10 |
| Q2 2025 | 20 | $2.5bn | 15 | 5 |
| Q3 2025 | 21 | $2.8bn | 13 | 8 |
| Q4 2025 | 20 | $3.9bn | 12 | 25 |
| Q1 2026 | 16 | $3.9bn | 13 | 22 |
| Q2 2026 | 12 | $5.8bn | 16 | 17 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
BIIB and GILD →BIIB and AMGN →BIIB and ARGX →Choose a stock to compare with BIIB →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own BIIB, latest filings →Back to the 13F Explorer →